LENZ Therapeutics, Inc. - LENZ
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Apr 27, 2026 | SCHEDULE 13G | BlackRock, Inc. | 5.8% | 1,804,099 | View |
| Apr 08, 2026 | SCHEDULE 13G | Squarepoint Ops LLC | 5.1% | 1,593,246 | View |
| Apr 08, 2026 | SCHEDULE 13G | Squarepoint Capital LLP | 5.1% | 1,593,246 | View |
| Apr 08, 2026 | SCHEDULE 13G | Squarepoint Operations Private Limited | 5.1% | 1,593,246 | View |
| Apr 08, 2026 | SCHEDULE 13G | Squarepoint (DIFC) Ltd | 5.1% | 1,593,246 | View |
| Apr 08, 2026 | SCHEDULE 13G | Squarepoint Master Fund Limited | 5.1% | 1,590,333 | View |
| Apr 08, 2026 | SCHEDULE 13G | Squarepoint Core Master Fund Limited | 0.0% | 2,913 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Ridgeback Capital Investments L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Ridgeback Capital Investments LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Ridgeback Capital Management LLC | 0.0% | 0 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 11.8% | 3,702,718 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 11.8% | 3,702,718 | View |
| Jan 21, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 4.9% | 1,537,723 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.